
DNLI vs ADMA
$DNLI vs $ADMA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNLI vs ADMA: the quick read
- ·DNLI is the larger company by market cap ($3.20B vs $2.18B).
- ·ADMA has been more active on our scanner (106 vs 96 alerts in 30 days).
- ·DNLI has the smaller float (143.1M vs 214.8M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 106 and 96 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 47% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: ADMA is outperforming the other by roughly 5.4 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNLI and ADMA on TheDesperateTrader.
- Is DNLI or ADMA the better stock?
- "Better" depends on your goal, and these two are not alike. DNLI is the larger company by market cap ($3.20B vs $2.18B). ADMA has been more active on our scanner (106 vs 96 alerts in 30 days). DNLI has the smaller float (143.1M vs 214.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNLI and ADMA?
- The differences that matter: they are not in the same business - DNLI is biological products, (no diagnostic substances) and ADMA is biological products, (no diagnostic substances); they are similar in size ($3.20B vs $2.18B); they trade at very different share prices ($19.91 vs $10.20); DNLI sits at 45% of its 52-week range against 23% for ADMA; our scanner flagged DNLI 96 times in the last 30 days against 106 for ADMA. Everything above is measured from the latest completed session and SEC filings.
- Which of DNLI and ADMA is more active right now?
- Right now DNLI is at about 1.1x its normal volume and ADMA is at about 1.1x, so DNLI is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNLI or ADMA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNLI and ADMA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.